Eurofins Amatsigroup

Foundation date

19/10/2007

Sector

#Biotechnology / R&D Services

Subsector

Eurofins CDMO is a leading international & innovative CDMO and a one-stop-shop partner guiding you from (pre-)clinical development to clinical manufacturing & logistics.
Our expertise lies in drug substance development & manufacturing for biologics and drug product development & manufacturing for small molecules and biologics.
We specifically have a long-term record in handling complex proteins, producing live/inactivated vaccines, enhancing strategies for compounds with low solubility (highway to clinic) and colon-targeted formulations.
We can offer a broad range of dosage forms and manufacturing can be performed in a non-sterile or sterile way, always supported by a large portfolio of analytical methods.
Eurofins CDMO is a trusted partner, where innovation is key to help customers with their life-saving medicines.

Latest news

  • Kurma Partners achieves first close of new EUR 250 million Biofund IV

    Thursday October 3rd 2024

  • Confo Therapeutics Announces Publication in Nature Communications Demonstrating First-Ever Structure of a Complex Between an Antibody-based Agonist and a Class A GPCR Regulating Hunger and Satiety

    Tuesday October 1st 2024

  • Obulytix appoints Dr. Kristof Van Emelen as Chief Executive Officer

    Tuesday October 1st 2024

Jobs by Eurofins Amatsigroup